CHARLESTON, S.C., Feb. 3, 2011 (GLOBE NEWSWIRE) -- Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCBB:RMCP) presented at the FSX (Financial Services Exchange) "Connect for Success" conference held January 27-29 in Atlanta, GA, and intends to present at the upcoming April 28-30 conference in San Francisco, CA. As the Company commences distribution of its first vacuum auto retractable RevVac™ safety syringe product over the next three months, it is imperative for the Company to gauge opinions and receive support from financial market professionals and to communicate the correct message to the investment community.
Ron Wheet, Chief Executive Officer and Chairman of Revolution's Medical remarked about the Company's presentation, "This was our first financial services conference and is a first step forward to receive the kind of professional exposure that the Company now desires from the financial investment community and market support resources. I am proud to say that the Company's RevVac™ safety syringe demonstrations and proprietary MRI Color 3D software tools were considered one of the highlights of the conference."
Tom O'Brien, the Company's President, and Ron Wheet were interviewed by host Shelly Kraft, Chief Executive Officer of SNN, Inc ( and ). Videos will be made available on early next week and include a live demonstration of the 3ml RevVac™ Safety Syringe.
StockVest.com, a premier internet destination for investors and financial planners seeking information on companies with emerging growth investment opportunities ("Stockvest"), has been engaged to represent Revolutions Medical at the upcoming 2011 World Money Show in Orlando, FL, February 9-12 and in Las Vegas, NV, May 9-12.
Art Brent, StockVest's Executive Director stated, "We are extremely excited to be involved in such a commercially viable product as the RevVac™ vacuum auto retractable safety syringe. In meeting with company team members at the Atlanta FSX conference, our executive staff quickly realized the amazing market potential of the high quality and patented technology offered by the RevVac™ safety syringe. The RevVac™ safety syringe is a real advancement in safety and medical technology and along with the RevColor™ MRI software tools, makes Revolutions Medical a step ahead of the competition."
About Revolutions Medical Corporation
Revolutions Medical is a safety medical device and software application company. Its products include the RevVac™ Safety Syringe (FDA approved), safety blood drawing device; and the RevColorTM, RevDisplayTM and Rev3DTM software tools that are compatible with standard MRIs and standard Picture Archiving Computer Systems (PACS). The Company also has an exclusive license to a Breast Biopsy System (BBS) preliminary called RevTrack (FDA approved).
For additional information, please visit Revolutions Medical corporate website:
To listen to a recent interview by Wall Street Reporter use the link provided below:
To be added to the Revolutions Medical investor email list, please email investment@revolutionsmedical.com with RMCP in the subject line.
Become a RevMed fan and follow the Company on Facebook -- visit http://www.Facebook.com/Revmed
FORWARD-LOOKING STATEMENTS
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.
CONTACT: Revolutions Medical Corporation Investor and Corporate Relations Brian John Rich Miller Mirador Consulting 1-877-Mirador
